The rise of Sildenafil initially fueled a boom for the drug industry, however recent shifts present a murky outlook for shareholders. Generic alternatives are reducing revenue, and continued litigation add additional https://blanchectac327954.bcbloggers.com/39988035/sildenafil-and-the-pharmaceutical-industry-a-volatile-bet